Evidence Hub

The Effects of Topiramate and Flunarizine on serum Glutamine and neuropeptide Y levels in adolescent Rats with a Migraine model

Nesrin Ceylan, Yıldıray Başbuğan

Revista Científica de la Facultad de Ciencias Veterinarias, 2025

8 participants

Abstract

This study aimed to investigate the effects of topiramate and flunarizine on serum glutamine and neuropeptide Y (NPY) levels in adolescent (6 weeks) rats with a migraine model induced by trinitroglycerin (NTG). For this purpose, 48 Wistar albino male rats in the adolescent stage were used. The rats were divided into 6 groups, each consisting of 8 animals. Group 1 (n=8): Healthy control group; no agent was applied. Group 2 (n=8): Migraine group; NTG (10 mg/kg, IP) was administered once daily. Group 3 (n=8): Migraine + Topiramate group; NTG (10 mg/ kg, IP) was administered once daily, and topiramate (50 mg) was administered orally twice a day. Group 4 (n=8): Migraine + Flunarizine group; NTG (10 mg/kg, IP) was administered once daily, and flunarizine (5 mg) was administered orally twice a day. Group 5 (n=8): Topiramate group only; topiramate (50 mg) was administered orally twice a day. Group 6 (n=8): Flunarizine group only; flunarizine (5 mg) was administered orally twice a day. All applications were performed for 5 days. In the migraine-induced group, a significant increase in glutamine and NPY levels was observed compared to the control group. However, in the topiramate and flunarizine groups (grup 5 and 6), no significant differences were detected in these levels compared to the control group. The NTG application was found to be suitable for creating a migraine model, but to observe better clinical findings, an increase in both dose and duration may be necessary. It was…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free